The impact of patient age on palliative care utilization and end-of-life outcomes among patients with metastatic breast cancer.

Authors

null

Carley Mitchell

University Hospitals, Department of Medicine, Cleveland, OH

Carley Mitchell , Nickolas Stabellini , Zhengyi Chen , Pingfu Fu , Alberto J. Montero

Organizations

University Hospitals, Department of Medicine, Cleveland, OH, Case Western Reserve University, Cleveland, OH, Case Western Reserve University School of Medicine, Department of Population and Quantitative Health Sciences, Cleveland, OH, Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, University Hospitals Seidman Cancer Center, Cleveland, OH

Research Funding

No funding received
None.

Background: Among patients with advanced cancer, palliative care (PC) utilization is frequently associated with improved quality of life, less aggressive end of life (EOL) measures, and hospice enrollment at the time of death. While older age is often associated with less PC utilization. The interplay between patient age, site and timing of PC with resultant EOL trends is not well understood. We aimed to assess these variations within a single institution’s metastatic breast cancer (mBC) population. Methods: An IRB approved retrospective study was conducted. All adult, decedent, mBC patients from 2011-2022 were analyzed. Manual chart review extracted demographic and clinical data related to diagnosis, treatment, PC utilization and death. The relationship of patient age with PC utilization (including setting and timing), aggressive EOL measures, hospice care at the time of death, and hospice duration were evaluated. Univariate analyses were conducted and factors with a significance level p < 0.15 were further evaluated on multivariable logistic regression. Results: 278 decedent mBC patients met inclusion criteria. Any form of PC interaction from date of metastatic diagnosis to date of death, and utilizing outpatient (OP) PC (i.e., only OP or OP + inpatient (IP)) during the last year of life were significantly associated with hospice enrollment at the time of death. Similarly, utilizing only OP PC (i.e., no IP) was significantly associated with a longer time on hospice care. There was a trend toward shorter hospice durations in mBC patients who received only IP PC, and patients who received any IP PC or had their first PC interaction < 4 months prior to the time of death were more likely to experience ≥ 1 aggressive EOL measure. Young adults (< 40) were significantly more likely to receive some form of PC throughout their disease course, with a trend toward receiving only IP PC. While no significant relationships were identified between age and EOL factors, there were trends toward young and middle-aged adults (40-64) receiving ≥ 1 aggressive EOL measure and less time on hospice compared to older adults (≥ 65). Conclusions: This study gives important insight into a breast cancer-specific female population. Results highlight the importance of PC, especially in the OP setting, and its effect on hospice enrollment prior to death. However, there appears to be an interesting dichotomy between young adults receiving more PC and worse EOL experiences compared to older adults receiving less PC and better EOL experiences. These results should guide and promote, early OP focused PC specifically for young and middle-aged adults to help improve challenging EOL transitions.

VariableOdds RatioUnivariate p-value Multivariate p-value
Any PC< 40 v 40-649.280.040.11
< 40 v ≥ 6510.950.03
Hospice care at time of deathAny PC v None2.390.010.01
Any OP PC v None2.890.020.04
≥ 3 weeks on hospiceOnly OP PC v None7.550.040.13

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Symptoms and Survivorship

Track

Symptom Science and Palliative Care

Sub Track

End-of-Life Care

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 12034)

DOI

10.1200/JCO.2023.41.16_suppl.12034

Abstract #

12034

Poster Bd #

402

Abstract Disclosures

Similar Abstracts

Abstract

2021 ASCO Quality Care Symposium

Hospitalization burden and end-of-life (EOL) care in elderly patients with glioblastoma (GBM).

First Author: Laura Donovan

First Author: Rushil Virendra Patel

First Author: Anshu Hemrajani

First Author: Amy An